245 related articles for article (PubMed ID: 38709466)
1. Measuring Quality of Life in Deprescribing Trials: A Scoping Review.
Thompson W; Lundby C; Bleik A; Waring H; Hong JA; Xi C; Hughes C; Salzwedel DM; McDonald EG; Pruskowski J; Scott S; Spinewine A; Kutner JS; Graabæk T; Elmi S; Moriarty F
Drugs Aging; 2024 May; 41(5):379-397. PubMed ID: 38709466
[TBL] [Abstract][Full Text] [Related]
2. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
Omuya H; Nickel C; Wilson P; Chewning B
Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
6. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
[TBL] [Abstract][Full Text] [Related]
7. Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature.
Pruskowski JA; Springer S; Thorpe CT; Klein-Fedyshin M; Handler SM
Drugs Aging; 2019 Dec; 36(12):1097-1110. PubMed ID: 31598908
[TBL] [Abstract][Full Text] [Related]
8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
9. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
Thillainadesan J; Gnjidic D; Green S; Hilmer SN
Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
[TBL] [Abstract][Full Text] [Related]
10. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
11. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Page AT; Clifford RM; Potter K; Schwartz D; Etherton-Beer CD
Br J Clin Pharmacol; 2016 Sep; 82(3):583-623. PubMed ID: 27077231
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for outcome measurement for deprescribing intervention studies.
Bayliss EA; Albers K; Gleason K; Pieper LE; Boyd CM; Campbell NL; Ensrud KE; Gray SL; Linsky AM; Mangin D; Min L; Rich MW; Steinman MA; Turner J; Vasilevskis EE; Dublin S
J Am Geriatr Soc; 2022 Sep; 70(9):2487-2497. PubMed ID: 35648465
[TBL] [Abstract][Full Text] [Related]
13. Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis.
Bloomfield HE; Greer N; Linsky AM; Bolduc J; Naidl T; Vardeny O; MacDonald R; McKenzie L; Wilt TJ
J Gen Intern Med; 2020 Nov; 35(11):3323-3332. PubMed ID: 32820421
[TBL] [Abstract][Full Text] [Related]
14. Validated medication deprescribing instruments for patients with palliative care needs palliative care: A systematic review.
de Andrade FK; Ignacio Nunes RP; Barboza Zanetti MO; Barboza Zanetti AC; Dos Santos M; de Oliveira AM; Carson-Stevens A; Leira Pereira LR; Rossi Varallo F
Farm Hosp; 2024; 48(2):T83-T89. PubMed ID: 38016841
[TBL] [Abstract][Full Text] [Related]
15. Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies.
Ross MSc Candidate SB; Wu PE; Atique Md Candidate A; Papillon-Ferland L; Tamblyn R; Lee TC; McDonald EG
J Am Geriatr Soc; 2020 Jul; 68(7):1594-1602. PubMed ID: 32142161
[TBL] [Abstract][Full Text] [Related]
16. Validated medication deprescribing instruments for patients with palliative care needs: a systematic review.
de Andrade FK; Nunes RPI; Zanetti MOB; Zanetti ACB; Dos Santos M; de Oliveira AM; Carson-Stevens A; Pereira LRL; Varallo FR
Farm Hosp; 2024; 48(2):83-89. PubMed ID: 37770284
[TBL] [Abstract][Full Text] [Related]
17. Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review.
Isenor JE; Bai I; Cormier R; Helwig M; Reeve E; Whelan AM; Burgess S; Martin-Misener R; Kennie-Kaulbach N
Res Social Adm Pharm; 2021 Jul; 17(7):1229-1241. PubMed ID: 32978088
[TBL] [Abstract][Full Text] [Related]
18. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions.
Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A
Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774
[TBL] [Abstract][Full Text] [Related]
19. How "age-friendly" are deprescribing interventions? A scoping review of deprescribing trials.
Wang J; Shen JY; Conwell Y; Podsiadly EJ; Caprio TV; Nathan K; Yu F; Ramsdale EE; Fick DM; Mixon AS; Simmons SF
Health Serv Res; 2023 Feb; 58 Suppl 1():123-138. PubMed ID: 36221154
[TBL] [Abstract][Full Text] [Related]
20. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
